IRVINE, Calif., April 12, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its first quarter 2012 financial results, which will take place on Thursday, April 26, 2012 after the close of the market.
